Pharmacokinetic (PK) Study of the 200 Microgram (mcg) Misoprostol Vaginal Insert (MVI 200) in Women at Term Gestation (The MVI-PK Study)

Clinical trial NCT01283022 · COMPLETED

Trial details

NCT number: NCT01283022
Sponsor: Ferring Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Ripening Induction of Labor

Start date: 2011-05-01
Primary completion: 2011-07-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.